Browsing: Studies

Would someone walking in a large public area, like a park or schoolyard, be more likely to turn toward the left or right? Turning left is more likely, leading people to circle counterclockwise, according to research published in the journal Nature Communications in June

England and CHICAGO, Aug. 25, 2026 /PRNewswire/ — Brainomix, a global leader in AI-powered imaging for stroke and lung disease, today announced that five abstracts showcasing its proprietary biomarkers and advanced CT analysis technologies will be presented at the European Respiratory Society (ERS) Congress 2026, taking place September 5–9 in Barcelona, Spain

(NEXSTAR) – From unexpected babies to “Ozempic teeth,” the ultra-popular class of GLP-1 medications is turning out to have a few unanticipated side effects

Professor Son Ki-young’s research team at Asan Medical Center in SeoulDepression and suicide experiences of people taking weight loss drugs ↑ The combined effects of the drug itself and psychological frustration a cure for obesity. [Yonhap News]

Oslo, 20 August 2026:  CEPI is providing US$4.17 million to four research projects designed to assess whether vaccines already or previously licensed against Zaire ebolavirus—including Ervebo—could offer protection against Bundibugyo ebolavirus, the virus behind the rapidly escalating outbreak in the Democratic Republic of the Congo, which was declared a Public Health Emergency of International Concern…

-ASC36_35FDC, a once-monthly subcutaneous (SQ) fixed dose combination (FDC) injection of ASC36 and ASC35, is a potentially first-in-class drug candidate which targets three validated targets of amylin receptor, GLP-1R and GIPR

In so many ways, it was the opposite of just about everything one might expect from a public meeting these days

Studies examine how self-service technology can expand health care access | Kiosk Marketplace

For nearly 58 years, the Monell Chemical Senses Center in University City has pioneered research into the ways our sense of taste and smell shape biology, behavior and the environmental factors of human health

“One of the most significant challenges in rare disease drug development is demonstrating treatment benefit when traditional randomized controlled trials (RCT) are not feasible. This recent research paper by Samuel H. Hughes, MBA and colleagues shared the following insights